Oxaliplatin-based platinum( iv ) complexes bearing axial alkoxido ligands were obtained by substituting the trifluoroacetato ligand. These complexes exhibit enhanced stability and reduced cytotoxicity compared to their carboxylated platinum( iv ) analogues.